Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Goldspan Health vs telos rx

Goldspan Health
Site position #169

Lower grade

vs+17.2
telos rx
Site position #14

Higher grade

The verdict

telos rx takes it — 85.4/100 to 68.2/100.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuetelos rx +51
36
87
Dose & formulationtelos rx +15
75
90
Clinical oversighttelos rx +7
77
84
Labs & monitoringGoldspan Health +17
97
80
FulfillmentGoldspan Health +2
89
87
Contract termstelos rx +35
45
80
Goldspan Health · left bartelos rx · right bar

The numbers

MetricGoldspan Healthtelos rx
WeighScore68.2/10085.4/100
GradeCB
Site position#169#14
Semaglutide$229 per 28 days (a single plan; thirteen charges a year)$99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks
Tirzepatide$299 per 28 days (a single plan; thirteen charges a year)$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
CoverageAll 50 states plus Washington, D.C.Not publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Goldspan Health

Site position #169 · C

Strengths

  • One plan per molecule with no tier ladder to read, which removes the commonest source of a misquoted price
  • Sublingual full-dose and microdose lines sit alongside the injections for readers who will not inject
  • States its compounding class — dispensed by a pharmacy licensed under 503A or 503B — rather than leaving it unsaid
  • Names a medical director and two clinical advisors by name and specialty
  • A lab panel is genuinely required at 60 to 90 days and annually after that, which is stronger monitoring than most of this ranking asks for

Where it loses points

  • The required lab panel is described as available at a low cost and its cost is stated nowhere on the site
  • The hero says “/month”, the plan card says billed every 28 days and the order timeline says every four weeks — thirteen charges a year, not twelve
  • “Pause, delay, or cancel at any time” on the storefront sits against a refund policy reading “all sales are final” and platform terms saying an order cannot be canceled once placed
  • The tirzepatide sublingual microdose page lists compounded sublingual semaglutide microdose in its own inclusion list
  • Clinicians are attributed to a partner platform while the storefront states it is not a medical practice
  • No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
  • Full-dose sublingual products exist on the catalog and are not linked from the site's own weight-loss page
telos rx

Site position #14 · B

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard